Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for March 22nd

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 22nd:

Fifth Third Bancorp (FITB - Free Report) : This diversified financial services company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 3.3%, compared with the industry average of 2.9%. Its five-year average dividend yield is 2.5%.

Fifth Third Bancorp Dividend Yield (TTM)

Fifth Third Bancorp Dividend Yield (TTM)

Fifth Third Bancorp dividend-yield-ttm | Fifth Third Bancorp Quote

First Commonwealth Financial Corporation (FCF - Free Report) : This consumer and commercial banking services provider has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 3.1%, compared with the industry average of 1.8%. Its five-year average dividend yield is 2.8%.

Great Western Bancorp, Inc. (GWB - Free Report) : This bank holding company for Great Western Bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 3%, compared with the industry average of 1.8%. Its five-year average dividend yield is 1.7%.

Bank of Montreal (BMO - Free Report) : This diversified financial services provider haswitnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 3.9%, compared with the industry average of 3.1%. Its five-year average dividend yield is 4%.

Bank Of Montreal Dividend Yield (TTM)

Bank Of Montreal Dividend Yield (TTM)

Bank Of Montreal dividend-yield-ttm | Bank Of Montreal Quote

See the full list of top ranked stocks here

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



More from Zacks Zacks #1 Rank Additions

You May Like